USPTO serial 79437432
KEY2BRAIN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- WUDARSKY, MINDY CHEK
- Law office
- TMO LAW OFFICE 117
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: 7 Aug 2026
Need help with KEY2BRAIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Office Action issues
The examiner has identified that your application faces a likelihood of confusion refusal and potential conflicts with earlier-filed applications, while also requiring updates to your goods descriptions, entity details, email address, and representation by a U.S.-licensed attorney.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical substances for use in the production of drugs; biological preparations for use in industry and science; biological preparations for use in science. | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of central nervous system [cns] diseases; pharmaceutical preparations for the treatment of diseases caused by bacteria; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceuticals; chemical reagents for medical or veterinary purposes; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of immune system related diseases and disorders. | ACTIVE | — |
| 042 | Technological research; technological services and research relating thereto; design and development of medical technology; science and technology services; technological analysis services; consultancy relating to biotechnology; research and development in the field of biotechnology; information on the subject of scientific research in the field of biochemistry and biotechnology; research relating to molecular sciences; analysis in the field of molecular biology; drug discovery services; research on the subject of pharmaceuticals; pharmaceutical drug development services; research and development for the pharmaceutical industry; consultancy relating to pharmaceutical research and development; technical research in the field of pharmaceutical studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 21, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 7, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 7, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 12, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 11, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 3, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 21, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 21, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 20, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |